Cross the
Final Frontier.
Human brain-on-chip technology for CNS drug development, neurotoxicity assessment, and neurological disease modeling. Break through the blood-brain barrier bottleneck.
Complete Neuroscience Platform
From blood-brain barrier penetration to neural network function, model the entire CNS drug pathway.
BBB-on-Chip
Human brain microvascular endothelial cells with astrocytes and pericytes forming functional tight junctions.
Neural Activity
MEA-based electrophysiology recording neural network formation, synchronization, and drug responses.
Permeability Assays
Quantitative measurement of drug transport across the BBB with efflux transporter characterization.
Disease Modeling
Patient iPSC-derived neurons recapitulating Alzheimer's, Parkinson's, ALS, and other conditions.
Seizure Liability
Proconvulsant risk assessment using synchronized neural network activity patterns.
Target Engagement
Confirm CNS target modulation with functional readouts beyond simple binding assays.
Neurological Disease Models
Patient-derived models for the most challenging neurological conditions.
Alzheimer's Disease
Amyloid-beta plaques, tau tangles, and neurodegeneration in human cortical neurons
Parkinson's Disease
Alpha-synuclein aggregation and dopaminergic neuron loss models
ALS
Motor neuron degeneration with patient-specific SOD1 and C9orf72 mutations
Epilepsy
Hyperexcitable neural networks for anti-seizure drug screening
Industry Leaders
Organizations advancing brain-on-chip technology for CNS drug discovery.
Own the Neuro Platform
NeuroChip.app - the premium domain for brain-on-chip technology and CNS drug development.
Inquire About This Domain